Exposure-response relationships and drug interactions of sirolimus
about
Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant PatientsCytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin.mTORC2 is required for proliferation and survival of TSC2-null cells.Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part ISirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy.Interaction of innovative small molecule drugs used for cancer therapy with drug transporters.Role of calcium in gene delivery.Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy.Liposomes as targeted drug delivery systems in the treatment of breast cancer.Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimusmTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis.Population pharmacokinetics of sirolimus in de novo Chinese adult renal transplant patients.Prolonged hypocalcemic effect by pulmonary delivery of calcitonin loaded poly(methyl vinyl ether maleic acid) bioadhesive nanoparticles.Phenytoin-induced reduction in sirolimus levels.Sex differences in transplantation.Pharmacokinetic and pharmacodynamic interactions between the immunosuppressant sirolimus and the lipid-lowering drug ezetimibe in healthy volunteers.The effect of rifampin on the pharmacokinetics of sirolimus in healthy volunteers.Significant sirolimus and dronedarone interaction in a kidney transplant recipient.Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.The potential of archaeosomes as carriers of pDNA into mammalian cells.Kinetic nomograms assist individualization of drug regimens.Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus.Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series
P2860
Q33432698-A499F1A4-41F9-4913-BAD6-45AF113AD74DQ33887999-12A8CA23-DB9F-42DE-95AF-EDF77F417569Q34177457-F5158995-04E9-460D-8B5E-AC9C5DECD2CDQ34610933-355E79D7-AC7F-4BC3-AAEF-C88A3A8A838EQ35130521-27C976FD-152B-48CA-8252-4D79039880DEQ35708124-81756D9A-68F3-48F3-AF2F-6B92F1D8681AQ36409049-D0B4D3D5-B61C-48F8-94BB-4260A2BC42F7Q36544981-AF2185CB-6A56-42C5-BB4E-88C30BC35003Q36554124-97B475B6-CAE2-4305-8EEB-D3CCF2BCA4B8Q36696454-719EF423-D6B0-4251-815D-677884137B7EQ36745445-82A9B412-B804-4A35-A962-2D640DDC2807Q37321421-602531E3-816F-4827-9040-96E1368D1546Q38256081-2CC54C58-02EC-47BF-8762-C40FC4135B15Q38261330-232C5D53-7BA2-40D9-9D71-8753AB836028Q38750337-2BA082DB-2403-40E3-A6CA-C2244AB94DB0Q39729168-A795C7AF-63B5-484F-B787-C0F8D7BF4275Q39810656-6A2C6192-5945-4FDB-B391-53254567F09FQ43059599-80215208-4E0D-4E8E-BB7C-A91C67A465F5Q46446644-44FEE512-B483-4655-BB2D-84C18876F0BEQ50440305-67C7303B-D3AB-4B83-B87D-0E549631A64EQ51497219-55DEBF08-36D5-4027-A453-F16EACB71021Q54585965-20F6699F-6D65-4C77-AB72-35588EB2F2D8Q58706984-64F341D0-BF99-49F1-983F-86306767474F
P2860
Exposure-response relationships and drug interactions of sirolimus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exposure-response relationships and drug interactions of sirolimus
@en
Exposure-response relationships and drug interactions of sirolimus.
@nl
type
label
Exposure-response relationships and drug interactions of sirolimus
@en
Exposure-response relationships and drug interactions of sirolimus.
@nl
prefLabel
Exposure-response relationships and drug interactions of sirolimus
@en
Exposure-response relationships and drug interactions of sirolimus.
@nl
P2860
P356
P1433
P1476
Exposure-response relationships and drug interactions of sirolimus
@en
P2093
James J Zimmerman
P2860
P2888
P356
10.1208/AAPSJ060428
P407
P577
2004-10-15T00:00:00Z
P5875
P6179
1009629078